Vystar Corp Stock Price, News & Analysis

Vystar Corporation (OTCQB: VYST) announced the completion of Phase 1 renovations at Rotmans Furniture, set to reopen on June 16. The remodel includes a redesigned entrance and bedding area, repurposing 90,000 sq. ft. of showroom into warehouse space, and introducing curated furniture lines. The recent "Closing to Remodel" sale exceeded all previous revenue records. CEO Steve Rotman emphasized improved customer service with quicker delivery options and a return to custom orders. The Grand Reopening Event is planned for fall following ongoing renovations.

Vystar Corporation's Rotmans Furniture will reopen on June 14 after completing Phase 1 of renovations, which involved redesigning the entry and bedding area and repurposing 90,000 sq. ft. of showroom into warehouse space for greater in-stock inventory. The remodel aims to enhance customer experience by providing a curated selection of furniture and immediate delivery options. The company experienced record sales during its remodeling event, exceeding previous quarterly revenues. Custom orders will also resume post-COVID, accommodating customer demand for bespoke furniture.

Vystar Corporation (OTCQB: VYST) has partnered with Nothing in the Air (NITA) to market its RxAir ultraviolet light air purifier line. NITA aims to enhance VYST's distribution through online and television marketing. The RxAir product is FDA-cleared and proven effective in eliminating airborne pathogens without chemicals. A ROKU advertising campaign launches on June 3, targeting Los Angeles and expanding to other platforms. The campaign emphasizes the importance of indoor air quality and the health benefits of the RxAir air purification system.

Vystar Corporation (OTCQB: VYST) reported record financial results for Q1 2021, with revenue of $12.87 million, up 117% year-over-year. The surge was attributed to a successful ‘Closing to Remodel’ sale at Rotmans Furniture and increased sales of RxAir UV air purifiers that eliminate over 99.6% of airborne pathogens. Gross profit rose to $6.79 million, a 126% increase. Net income reached $918,127, compared to a loss of $1.37 million in Q1 2020. Operating expenses increased by 51% to $5.82 million, primarily due to heightened advertising and third-party agent fees.

Vystar Corporation (OTCQB: VYST) has appointed Byron Novosad, DDS, to its Board of Directors, replacing retired member Keith Osborn, MD. CEO Steve Rotman expressed gratitude for Dr. Osborn's service and welcomed Dr. Novosad, noting his extensive experience and commitment as an investor and advisor. Dr. Novosad aims to enhance shareholder value through strategic execution and communication of Vystar's vision, particularly in health-related product lines such as RxAir UV purifiers and Vytex deproteinized latex. His background and insights are expected to positively influence Vystar's future growth.

Vystar Corporation (OTCQB: VYST) has partnered with 5W Public Relations to enhance media presence and brand recognition for its RxAir UV light air purification products. This collaboration aims to address growing consumer concerns about airborne disease transmission due to the COVID-19 pandemic. 5WPR will implement a targeted media relations program and influencer campaigns to promote RxAir's effectiveness in eliminating 99.9% of airborne viruses, including various strains of coronaviruses. RxAir products are FDA cleared as Class II Medical Devices, designed initially for healthcare environments.

Vystar Corporation (OTCQB: VYST) has partnered with Corrie MacColl Limited for global market development and distribution of Vytex deproteinized latex. The three-year agreement allows Corrie MacColl to utilize its extensive supply chain and sustainability practices to produce Vytex from its eco-friendly Cameroon plantations. This partnership aims to enhance Vytex's global reach, expected to add shareholder value without significant costs, and positions Vystar to enter new markets in sustainable applications for products like tires and medical devices.

Vystar Corporation (OTCQB: VYST) reports significant advancements amid COVID-19 challenges, enhancing its supply chain and product offerings, particularly through its RxAir UV air purifiers, which have seen increased demand. The company produced over 10,000 units of the RxAir 400 and aims to manufacture the Rx3000 by Q1 2021. Additionally, Rotmans Furniture expects a surge in sales due to a clearance sale and renovation plans. The company is pursuing strategic partnerships to support growth while minimizing debt. Vystar remains committed to spinning off RxAir as a public entity, enhancing shareholder value.